To enhance clinical trial material manufacturing capabilities
MedPharm and Molecular Profiles have formed a dedicated topical medicine manufacturing service for clinical trial material.
The UK firms will provide small-scale clinical trial supplies, including more complex new chemical entities (NCEs), to help customers get to proof of concept in clinical trials (Phase II) as early as possible.
No financial details were revealed.
Guildford, Surrey-based MediPharm’s ceo Andrew Muddle said the partnership would allow the firm to offer an expanded range of GMP services to customers.
Nikin Patel, ceo of Molecular Profiles, which is based in Nottingham, added that the alliance with MedPharm ‘is an opportunity for both companies to expand our service offerings within topical drug delivery’.